Literature DB >> 27796864

Functional Mitral Regurgitation: Appraising the Evidence Behind Recommended Treatment Strategies.

Zainab Samad1, Eric J Velazquez2,3.   

Abstract

Functional mitral regurgitation (MR) is the most common type of MR encountered in clinical practice. Because the disease arises from the ventricular aspect of the mitral valve apparatus, treatment therapies are less defined and outcomes are poor. In this review, the state of evidence for medical and surgical therapy in functional MR is appraised. Future directions for research in this area are also defined.

Entities:  

Keywords:  Functional mitral regurgitation; Medical therapy; Mitraclip; Mitral valve replacement; Surgery

Mesh：

Year:  2016        PMID： 27796864     DOI： 10.1007/s11886-016-0808-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  48 in total

Review 1.  Defining "severe" secondary mitral regurgitation: emphasizing an integrated approach.

Authors:  Paul A Grayburn; Blasé Carabello; Judy Hung; Linda D Gillam; David Liang; Michael J Mack; Patrick M McCarthy; D Craig Miller; Alfredo Trento; Robert J Siegel
Journal:  J Am Coll Cardiol       Date:  2014-12-30       Impact factor: 24.094

Review 2.  Percutaneous transcatheter mitral valve replacement: an overview of devices in preclinical and early clinical evaluation.

Authors:  Ole De Backer; Nicolo Piazza; Shmuel Banai; Georg Lutter; Francesco Maisano; Howard C Herrmann; Olaf W Franzen; Lars Søndergaard
Journal:  Circ Cardiovasc Interv       Date:  2014-06       Impact factor: 6.546

3.  Impact of cardiac resynchronization therapy on the severity of mitral regurgitation.

Authors:  Luigi Di Biase; Angelo Auricchio; Prasant Mohanty; Rong Bai; Josef Kautzner; Paolo Pieragnoli; Francois Regoli; Antonio Sorgente; Giulio Spinucci; Giuseppe Ricciardi; Antonio Michelucci; Laura Perrotta; Francesco Faletra; Hancha Mlcochová; Kamil Sedlacek; Robert Canby; Javier E Sanchez; Rodney Horton; J David Burkhardt; Tiziano Moccetti; Luigi Padeletti; Andrea Natale
Journal:  Europace       Date:  2011-04-12       Impact factor: 5.214

4.  Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure.

Authors:  B D Lowes; E A Gill; W T Abraham; J R Larrain; A D Robertson; M R Bristow; E M Gilbert
Journal:  Am J Cardiol       Date:  1999-04-15       Impact factor: 2.778

5.  Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction.

Authors:  Audrey H Wu; Keith D Aaronson; Steven F Bolling; Francis D Pagani; Kathy Welch; Todd M Koelling
Journal:  J Am Coll Cardiol       Date:  2005-02-01       Impact factor: 24.094

6.  Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study.

Authors:  K Jane Grande-Allen; Allen G Borowski; Richard W Troughton; Penny L Houghtaling; Nicholas R Dipaola; Christine S Moravec; Ivan Vesely; Brian P Griffin
Journal:  J Am Coll Cardiol       Date:  2005-01-04       Impact factor: 24.094

7.  Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure.

Authors:  Benjamin H Trichon; G Michael Felker; Linda K Shaw; Christopher H Cabell; Christopher M O'Connor
Journal:  Am J Cardiol       Date:  2003-03-01       Impact factor: 2.778

8.  Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Authors:  L W Stevenson; D Bellil; M Grover-McKay; R C Brunken; M Schwaiger; J H Tillisch; H R Schelbert
Journal:  Am J Cardiol       Date:  1987-09-15       Impact factor: 2.778

9.  Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Lung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala
Journal:  Eur J Cardiothorac Surg       Date:  2012-08-25       Impact factor: 4.191

10.  Mitral-valve repair versus replacement for severe ischemic mitral regurgitation.

Authors:  Michael A Acker; Michael K Parides; Louis P Perrault; Alan J Moskowitz; Annetine C Gelijns; Pierre Voisine; Peter K Smith; Judy W Hung; Eugene H Blackstone; John D Puskas; Michael Argenziano; James S Gammie; Michael Mack; Deborah D Ascheim; Emilia Bagiella; Ellen G Moquete; T Bruce Ferguson; Keith A Horvath; Nancy L Geller; Marissa A Miller; Y Joseph Woo; David A D'Alessandro; Gorav Ailawadi; Francois Dagenais; Timothy J Gardner; Patrick T O'Gara; Robert E Michler; Irving L Kron
Journal:  N Engl J Med       Date:  2013-11-18       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.